Natural Biocon (India) Ltd
₹ 12.0
1.18%
22 Nov
- close price
About
Incorporated in 1992, Natural Biocon Ltd trades in chemicals, natural extracts, agricultural produce and commodities[1]
Key Points
- Market Cap ₹ 30.9 Cr.
- Current Price ₹ 12.0
- High / Low ₹ 14.8 / 8.33
- Stock P/E 68.6
- Book Value ₹ 12.5
- Dividend Yield 0.00 %
- ROCE 1.85 %
- ROE 1.22 %
- Face Value ₹ 10.0
Pros
- Company has reduced debt.
- Company is almost debt free.
- Stock is trading at 0.96 times its book value
- Debtor days have improved from 229 to 131 days.
- Company's working capital requirements have reduced from 227 days to 24.3 days
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Promoter holding has decreased over last quarter: -11.9%
- Promoter holding is low: 9.36%
- Company has a low return on equity of 1.10% over last 3 years.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Loading peers table ...
Quarterly Results
Figures in Rs. Crores
Profit & Loss
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|
| 0.05 | 0.15 | 1.04 | 0.45 | 0.00 | 0.13 | 0.48 | 1.25 | 13.53 | 19.26 | |
| 0.05 | 0.04 | 0.04 | 0.34 | 0.03 | 0.13 | 0.39 | 1.00 | 13.30 | 18.74 | |
| Operating Profit | 0.00 | 0.11 | 1.00 | 0.11 | -0.03 | 0.00 | 0.09 | 0.25 | 0.23 | 0.52 |
| OPM % | 0.00% | 73.33% | 96.15% | 24.44% | 0.00% | 18.75% | 20.00% | 1.70% | 2.70% | |
| 0.00 | 0.00 | 0.00 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| Interest | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.00 | 0.11 | 1.00 | 0.12 | -0.03 | 0.00 | 0.09 | 0.25 | 0.23 | 0.52 |
| Tax % | 27.27% | 30.00% | 41.67% | 166.67% | 22.22% | 28.00% | 30.43% | |||
| 0.00 | 0.08 | 0.70 | 0.07 | -0.08 | 0.00 | 0.07 | 0.18 | 0.15 | 0.45 | |
| EPS in Rs | 0.00 | 0.07 | 0.62 | 0.06 | -0.07 | 0.00 | 0.06 | 0.16 | 0.13 | 0.30 |
| Dividend Payout % | 0.00% | 0.00% | 81.21% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 98% |
| 3 Years: | 370% |
| TTM: | 305% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | 16% |
| 3 Years: | % |
| TTM: | 22% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | -11% |
| 1 Year: | 12% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | 1% |
| 3 Years: | 1% |
| Last Year: | 1% |
Balance Sheet
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 11.37 | 25.78 |
| Reserves | 0.00 | 0.01 | 0.64 | 0.64 | 0.61 | 0.61 | 0.68 | 0.86 | 1.01 | 6.35 |
| 0.00 | 0.00 | 0.00 | 0.82 | 0.68 | 0.36 | 0.16 | 0.15 | 0.07 | 0.00 | |
| 0.03 | 0.13 | 0.42 | 0.19 | 0.05 | 0.04 | 0.08 | 1.13 | 4.32 | 4.13 | |
| Total Liabilities | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 36.26 |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | |
| CWIP | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 | 3.29 |
| Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 19.53 |
| 8.11 | 8.22 | 9.14 | 9.73 | 9.42 | 9.09 | 8.99 | 10.21 | 13.47 | 13.43 | |
| Total Assets | 11.40 | 11.51 | 12.43 | 13.02 | 12.71 | 12.38 | 12.29 | 13.51 | 16.77 | 36.26 |
Cash Flows
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| 0.04 | 0.21 | -0.04 | -0.86 | 0.15 | 0.32 | 0.18 | 0.21 | -0.12 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -0.01 | 0.00 | 0.00 | |
| 0.00 | -0.07 | -0.07 | 0.75 | -0.14 | -0.32 | 0.00 | -0.02 | -0.09 | |
| Net Cash Flow | 0.04 | 0.15 | -0.11 | -0.11 | 0.01 | 0.00 | 0.17 | 0.19 | -0.21 |
Ratios
Figures in Rs. Crores
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 0.00 | 0.00 | 357.98 | 632.67 | 1,460.00 | 372.60 | 183.96 | 131.38 | |
| Inventory Days | 821.25 | 547.50 | 381.59 | 4.61 | |||||
| Days Payable | 0.00 | 0.00 | 423.07 | 117.83 | |||||
| Cash Conversion Cycle | 821.25 | 547.50 | 357.98 | 632.67 | 1,460.00 | 372.60 | 142.48 | 18.16 | |
| Working Capital Days | 7,665.00 | 2,238.67 | 572.07 | 1,346.44 | 4,829.23 | 479.06 | 178.12 | 24.28 | |
| ROCE % | 0.97% | 8.55% | 0.97% | -0.24% | 0.00% | 0.73% | 2.03% | 1.85% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Newspaper Publication
2d - Newspaper clipping for corrigendum to EGM notice.
-
Corrigendum/Errata To The Notice Of EGM Notice Dated October 30, 2024
18 Nov - Approval of corrigendum for EGM notice and share issuance.
-
Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
18 Nov - Board approved increase in share capital and acquisitions.
-
Board Meeting Outcome for Announcement Under Regulation 30 Of SEBI (LODR) Regulations, 2015
18 Nov - Approval for acquisition of WAIL and TMPL shares.
-
Unaudited Financial Result For The Quarter And Half Year Ended September 30, 2024.
9 Nov - Board approved unaudited financial results for Q2 2024.
Business Overview:[1]
Company is in the business of extracting, procuring, crushing, separating, trading and dealing in plants, seeds, agriculture produce
and all types of vegetation, juices, and alkaloids viz. nicotine, caffeine, tannin, morphine, codeine, strychnine, nuxvomicase, brucine and manufacture of all types of Agro chemicals, for barely malt, maltose, malt sugar, and its derivatives. Company also plans to venture into agriculture produce, marine, solar and infrastructure